Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Tissue factor (TF) is a transmembrane glycoprotein to initiate blood coagulation and frequently overexpressed in a variety of tumors. Our previous study has showed that the expression of TF is upregulated and correlated with prognosis in hepatocellular carcinoma (HCC). However, the role and molecula...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Huang, Shan-Zhou, Wei, Meng-Ning, Huang, Jia-Rong, Zhang, Zi-Jian, Zhang, Wen-Ji, Jiang, Qi-Wei, Yang, Yang, Wang, Huan-Yu, Jin, Hui-Lin, Wang, Kun, Xing, Zi-Hao, Yuan, Meng-Ling, Li, Yao, He, Xiao-Shun, Shi, Zhi, Zhou, Qi
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6428933/
https://ncbi.nlm.nih.gov/pubmed/30931258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00150
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires